These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 522637)
41. The pharmacokinetics and dynamics of oxprenolol: a simulation study with six subjects. Saunders L; Ingram D; Warrington SJ J Pharm Pharmacol; 1985 Nov; 37(11):802-6. PubMed ID: 2867161 [TBL] [Abstract][Full Text] [Related]
42. Pose estimation and motion analysis of ski jumpers based on ECA-HRNet. Bao W; Niu T; Wang N; Yang X Sci Rep; 2023 Apr; 13(1):6132. PubMed ID: 37061550 [TBL] [Abstract][Full Text] [Related]
44. The importance of being light: aerodynamic forces and weight in ski jumping. Schmölzer B; Müller W J Biomech; 2002 Aug; 35(8):1059-69. PubMed ID: 12126665 [TBL] [Abstract][Full Text] [Related]
45. The effect of wind on jumping distance in ski jumping depends on jumpers' aerodynamic characteristics. Mikko V; Juha K J Biomech; 2022 May; 137():111101. PubMed ID: 35490447 [TBL] [Abstract][Full Text] [Related]
46. Effect of oxprenolol on heart rate. Hedges A; Turner P Br Med J; 1973 Feb; 1(5850):422. PubMed ID: 4691086 [No Abstract] [Full Text] [Related]
47. Pursuit of "eucardia". Vaisrub S JAMA; 1978 Oct; 240(17):1893. PubMed ID: 691203 [No Abstract] [Full Text] [Related]
48. Ocular reaction to oxprenolol. A case report. Lewis BS; Setzen M; Kokoris N S Afr Med J; 1976 Mar; 50(12):482-3. PubMed ID: 131980 [TBL] [Abstract][Full Text] [Related]
49. Performance and jump-to-jump development in the first female ski flying competition in history. Elfmark O; Sandbakk Ø; Brevig M; Ettema G Front Sports Act Living; 2024; 6():1366042. PubMed ID: 38752211 [TBL] [Abstract][Full Text] [Related]
50. Oxprenolol in the operating-theatre. Jourdan MH Lancet; 1978 Jul; 2(8080):111. PubMed ID: 78282 [No Abstract] [Full Text] [Related]
51. The effects of beta-adrenergic stimulation and beta-adrenergic blockade on emotional reactions. Erdmann G; van Lindern B Psychophysiology; 1980 Jul; 17(4):332-8. PubMed ID: 6248918 [No Abstract] [Full Text] [Related]
52. Reducing the somatic manifestations of anxiety by beta-blockade--a study of stage fright. James IM; Pearson RM; Griffith DN; Newbury P; Taylor SH J Psychosom Res; 1978; 22(4):327-37. PubMed ID: 739420 [No Abstract] [Full Text] [Related]
53. Possible immunological effect of oxprenolol. Nessi R Br Med J; 1977 Feb; 1(6058):446. PubMed ID: 837159 [No Abstract] [Full Text] [Related]
54. After the fall: symptoms in bungee jumpers. Young CC; Raasch WG; Boynton MD Phys Sportsmed; 1998 May; 26(5):75-8. PubMed ID: 20086815 [TBL] [Abstract][Full Text] [Related]
55. Possible immunological effect of oxprenolol. McMahon LF Br Med J; 1976 Dec; 2(6048):1388. PubMed ID: 1000250 [No Abstract] [Full Text] [Related]
56. [Influence of physical exertion on the development of the pelvis]. Kliment V; Schmidt P; Zajac J Bratisl Lek Listy; 1971; 56(1):64-7. PubMed ID: 5564274 [No Abstract] [Full Text] [Related]
57. Thrombocytopenia secondary to oxprenolol, a beta-blocking agent. Patrassi GM; Casonato A; Fabris F; Girolami A Acta Haematol; 1982; 68(1):75-6. PubMed ID: 6812363 [No Abstract] [Full Text] [Related]
58. Drug fever due to oxprenolol. Hasegawa K; Sakamoto Y; Mitsunaga K; Kashiwagi H Br Med J; 1980 Jul; 281(6232):27-8. PubMed ID: 7407486 [No Abstract] [Full Text] [Related]
59. Letter: Oxprenolol and a psoriasis-like eruption. Leonard JC Lancet; 1975 Mar; 1(7907):630. PubMed ID: 47968 [No Abstract] [Full Text] [Related]
60. What Is So Special about Wingsuit BASE Jumpers? A Comparative Study of Their Psychological Characteristics. Bouchat P; Feletti F; Monasterio E; Brymer E Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]